Sterne Kessler’s infectious disease team helps clients protect and defend the drug and vaccine innovations they make in the fight against infectious diseases.
The infectious diseases team integrates knowledge in small molecule chemistry, biotechnology, pathogenesis, immunology and treatment methods on behalf of companies and organizations innovating in the infectious diseases sector.
Our integrated team is perfectly positioned to provide strategic IP services to companies and organizations innovating in the infectious diseases sector. Our services include patent portfolio strategy, freedom-to-operate analyses (including design around counseling and market clearance for diagnostics and treatments), patentability analyses, patent procurement, licensing, cooperative research and development agreements, and litigation (including at the USITC).
We have experience in areas such as:
- Vaccines
- Adjuvants
- Anti-infectives including:
- Antivirals
- Antibiotics and other antibacterials
- Biodefense
- Virulence markers
- Personalized medicine
- Diagnostic assays
- Biologics